- Home
- IPHA vs KLTR Comparison
IPHA vs KLTR Comparison
Compare IPHA & KLTR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- IPHA
- KLTR
- Stock Information
- Founded
- IPHA 1999
- KLTR 2006
- Country
- IPHA France
- KLTR United States
- Employees
- IPHA N/A
- KLTR N/A
- Industry
- IPHA Biotechnology: Pharmaceutical Preparations
- KLTR EDP Services
- Sector
- IPHA Health Care
- KLTR Technology
- Exchange
- IPHA Nasdaq
- KLTR Nasdaq
- Market Cap
- IPHA 191.0M
- KLTR 177.3M
- IPO Year
- IPHA 2019
- KLTR 2021
- Fundamental
- Price
- IPHA $2.28
- KLTR $1.26
- Analyst Decision
- IPHA Strong Buy
- KLTR Buy
- Analyst Count
- IPHA 1
- KLTR 3
- Target Price
- IPHA $11.50
- KLTR $2.67
- AVG Volume (30 Days)
- IPHA 5.5K
- KLTR 99.9K
- Earning Date
- IPHA 09-12-2024
- KLTR 11-06-2024
- Dividend Yield
- IPHA N/A
- KLTR N/A
- EPS Growth
- IPHA N/A
- KLTR N/A
- EPS
- IPHA N/A
- KLTR N/A
- Revenue
- IPHA $36,202,722.00
- KLTR $176,832,000.00
- Revenue This Year
- IPHA N/A
- KLTR $2.29
- Revenue Next Year
- IPHA $105.84
- KLTR $2.32
- P/E Ratio
- IPHA N/A
- KLTR N/A
- Revenue Growth
- IPHA 6.88
- KLTR 2.65
- 52 Week Low
- IPHA $1.81
- KLTR $0.76
- 52 Week High
- IPHA $3.15
- KLTR $2.03
- Technical
- Relative Strength Index (RSI)
- IPHA 50.55
- KLTR 51.22
- Support Level
- IPHA $2.27
- KLTR $1.18
- Resistance Level
- IPHA $2.41
- KLTR $1.26
- Average True Range (ATR)
- IPHA 0.11
- KLTR 0.08
- MACD
- IPHA -0.00
- KLTR -0.00
- Stochastic Oscillator
- IPHA 52.94
- KLTR 49.23
About IPHA Innate Pharma S.A. ADS
Innate Pharma SA is a clinical-stage biotechnology company. It is engaged in developing immunotherapies for cancer patients. Its approach is to harness the innate immune system through therapeutic antibodies and its ANKET (Antibody-based NK cell Engager Therapeutics) proprietary platform. The company's revenue results from payments received to research, collaboration, and licensing agreements signed with pharmaceutical companies. Its product pipeline includes lacutamab, monalizumab, IPH5201, IPH5301, IPH6101, IPH62, IPH6401 and IPH6501.
About KLTR Kaltura Inc.
Kaltura Inc provides live and on-demand video SaaS solutions to thousands of organizations around the world, engaging hundreds of millions of viewers at home, at work, and at school. It also offers specialized industry solutions, including Learning Management System Video, Lecture Capture, and Virtual Classroom for educational institutions, as well as a TV Solution for media and telecom companies. It operates in two reporting segments which are Enterprise, Education, and Technology, and Media and Telecom. The majority of the revenue is derived from Enterprise, Education & Technology. The majority of the revenue is earned from the United States.